Life Sciences Industry
Balancing the corporate outlook between existing products and products in the new product pipeline is a critical success factor in managing a Life Sciences company.
Through providing the clearest view of the forecast for the portfolio of existing products, RoadMap GPS; statistical modeling,scenario planning, collaboration technology and forecast exception reporting allow companies to analyze the potential gap between existing products and the portfolio of new products.
Consistent revenue forecasting from one financial quarter to the next builds confidence in the financial community in the ability of management to deliver consistent results for their shareholders.
From Pandemic to Endemic: Will the Omicron Variant Turn COVID-19 into a Seasonal Flu Next Winter?
And just like that…the Omicron Variant exploded on the world, slamming the US right over the holidays, quadrupling the number of new COVID cases over a three-week period, with currently more than five million new cases reported per week. Healthcare systems, which were already dealing with overworked staff from twenty
CASE STUDY: Why Pharmaceutical Market Access is Dependent on Risk Sharing and Persistency Modeling
ABSTRACT In our case study for injectable Migraine medication, the higher patient persistency curve for patients with a lower co-pay increases drug utilization by 20%, while lowering payor price by 26% and payor total cost by 11%. What is Market Access? It’s the process that ensures that all patients, who
Why Cannabis will be bigger than Beer in US by 2025
Market Research Project Video discussing the emergence of a brand new industry due to changes in legislation and policies. This video is originally based off a regression analysis project looking at a multitude of different data quantifying the size and demand of the market in the United States for Cannabis.
You must be logged in to post a comment.